Juvenile Polyposis Syndrome — ESEGH MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Juvenile polyposis syndrome; SMAD4 pathogenic variant
This is juvenile polyposis syndrome (JPS), with the family’s hereditary haemorrhagic telangiectasia phenotype indicating a SMAD4 pathogenic variant. The number of histologically characteristic juvenile polyps and the affected first-degree relative independently satisfy clinical criteria for JPS. JPS may result from SMAD4 or BMPR1A variants, but pulmonary arteriovenous malformations and recurrent epistaxis specifically favour SMAD4-associated JPS–HHT overlap. Peutz–Jeghers polyps have arborising smooth-muscle cores and are associated with mucocutaneous pigmentation. Cowden syndrome usually features macrocephaly and characteristic mucocutaneous lesions. FAP produces numerous adenomatous rather than juvenile hamartomatous polyps, while Lynch syndrome predisposes to colorectal cancer without a juvenile polyposis phenotype.
Reference: Monahan KJ et al. BSG/ACPGBI/UKCGG guidelines for the management of hereditary colorectal cancer, section “Juvenile polyposis syndrome”, 2020. https://www.bsg.org.uk/BSG/media/BSG-Media/Guidelines-for-the-management-of-hereditary-colorectal-cancer-full_.pdf